Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.720
+0.010 (0.58%)
At close: Nov 6, 2026, 4:00 PM EST
1.730
+0.010 (0.58%)
After-hours: Nov 6, 2026, 7:30 PM EST
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $162.84 million as of November 6, 2026. It is the 21,671st most valuable company in the world and the 3,692nd biggest in the United States. Its market cap has increased by 68.46% in one year.
Market Cap
162.84M
Enterprise Value
25.92M
1-Year Change
68.46%
Global Rank
Country Rank
#3,692 United States
Category
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $162.84M, a decrease of -72.28%. That is a compound annual growth rate of -17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 162.84M | 86.28% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 176.91M |
| Entrada Therapeutics | 176.32M |
| PepGen | 171.07M |
| Invivyd | 165.95M |
| Canton Strategic Holdings | 164.14M |
| BridgeBio Oncology Therapeutics | 163.56M |
| Oramed Pharmaceuticals | 160.57M |
| ALX Oncology Holdings | 159.71M |